Top member reports
Consensus community valuation
Active Member Straws
#ASX Announcements
Last edited 5 days ago

20 May 2020: Exenatide (their lead drug) Phase II results were read out and were very positive.  Company is in a trading halt and raising capital. 

Fiftyone Capital were on top of this opportunity and called it out on livewire and other places.  https://www.fiftyonecapital.com/home

View Attachment

Read More